Canna Law Blog
OCTOBER 12, 2022
Based upon it’s “scientific and medical evaluation”, the FDA found marijuana supremely dangerous and formally recommended that the plant remain in schedule I. For anyone also wondering what effect re-scheduling would have on state-level industry, check out this old chestnut from 2016. I won’t repeat why that result would be bad.
FloridaMarijuana.net
JULY 16, 2018
Luckily, the trepidation of getting caught with medical marijuana has an easy solution nowadays. The initial payment will cover the medical evaluation, and three different recommendations for medical cannabis, which will last for seven months.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 30, 2019
To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Both DOJ and HHS agreed to conduct a medical and scientific evaluation of CBD independent of marijuana in 2015.
Canna Law Blog
AUGUST 31, 2023
As an HHS spokesperson explained: “While HHS’s scientific and medical evaluation is binding on DEA, the scheduling recommendation is not. For a fuller analysis, check out this old chestnut from 2016. But would moving marijuana to Schedule III make the risk of federal enforcement even more unlikely?
Cannabis Law Report
MARCH 25, 2019
The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). 2122 ) (relating to prohibitions governing atomic weapons), or section 104(a) of the North Korea Sanctions Enforcement Act of 2016 ? [3]
Expert insights. Personalized for you.
84 
Let's personalize your content